As of January 2025 Inhibrx has a market cap of ₹17.43 Billion. This makes Inhibrx the world's 8229th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2025 the market cap of Inhibrx was reported to be: